Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT07618273
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 44 Years
Healthy Volunteers
Accepted

Interventions

  • Artificial Intelligence-based Intervention — OTHER
    Engage with the Smart Symptom Tracking ALEX app
  • Best Practice — OTHER
    Complete paper logs
  • Communication Intervention — OTHER
    Receive reminders
  • Questionnaire Administration — OTHER
    Ancillary studies

Study Details

This clinical trial compares the impact of the Smart Symptom Tracking ALEX application (app) to standard symptom-tracking practices in tracking and monitoring gastrointestinal (GI) symptoms in young adults. Rates of early-onset colorectal cancer are rising sharply and it is projected to become the leading cause of cancer-related death in young adults. Despite this, adults under 45 still face barriers to diagnosis, including access to screening, unclear guidance on the impact of GI symptoms and dismissal of symptoms by healthcare providers. Current screening guidelines lack guidance on monitoring early symptoms in younger adults. The Smart Symptom Tracking ALEX tool is a digital platform that uses artificial intelligence to provide prompts for symptoms, coaching, reminders and education. Standard of care clinical practices include paper-based logs to report symptoms. Using the Smart Symptom Tracking ALEX app may provide more detailed symptom reports and increase self-reported symptom communication compared to standard symptom-tracking practices in young adults concerned about their GI health.

Key Dates

Start date
Apr 20, 2026
Status verified
Jun 2026
Primary completion
Apr 20, 2027
Completion
Apr 20, 2029

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Experimental: Arm 1 (Smart Symptom Tracking ALEX)
    Participants engage with the Smart Symptom Tracking ALEX app daily and receive reminders weekly for 4 weeks.
  • Active Comparator: Arm 2 (paper logs)
    Participants complete paper logs daily and receive reminders weekly for 4 weeks.

Primary Outcome Measure

Change in gastrointestinal self-advocacy [ Time Frame: At baseline and at 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Enhancing Technology & Communication in Healthcare (ETCH) Lab
904-953-5375
Clinical Trials Referral Office
855-776-0015
Janice L. Krieger, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Jacksonville, FL

By condition

Related Studies